Biotech · Private company
Avid Radiopharmaceuticals
Track this companyFree. Adds Avid Radiopharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials255 recruiting or active
Pipeline programs20From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline20
- Brain PET ScanPhase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Brain PET ScanPhase 3 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- florbetapir F 18Phase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- flortaucipir F 18Phase 3 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- flortaucipir F18Phase 3 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Flortaucipir F18Phase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PET ScanPhase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- florbetapir F 18Phase 2 · Chronic Traumatic EncephalopathyClinicalTrials.gov · fetched Nov 12, 2026
- Flortaucipir F18Phase 2 · Chronic Traumatic EncephalopathyClinicalTrials.gov · fetched Nov 12, 2026
- 18F-LY3950321Phase 1 · Diagnostic Agent Adverse ReactionClinicalTrials.gov · fetched Nov 12, 2026
- Brain MRIPhase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Brain PET scanPhase 1 · Frontotemporal DementiaClinicalTrials.gov · fetched Nov 12, 2026
- Brain PET scanPhase 1 · Cognitive DeclineClinicalTrials.gov · fetched Nov 12, 2026
- Brain PET scanPhase 1 · Progressive Supranuclear PalsyClinicalTrials.gov · fetched Nov 12, 2026
- Florbetapir F 18Phase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Flortaucipir F18Phase 1 · Frontotemporal DementiaClinicalTrials.gov · fetched Nov 12, 2026
- Flortaucipir F18Phase 1 · Cognitive DeclineClinicalTrials.gov · fetched Nov 12, 2026
- Flortaucipir F18Phase 1 · Progressive Supranuclear PalsyClinicalTrials.gov · fetched Nov 12, 2026
- PET ScanPhase 1 · Diagnostic Agent Adverse ReactionClinicalTrials.gov · fetched Nov 12, 2026
- Whole body PET scanPhase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- 18F-LY3950321-01 Biodistribution and Safety StudyEARLY_PHASE1 · COMPLETED · started Feb 28, 2023ClinicalTrials.gov NCT05775601 · fetched Nov 12, 2026
- University of Pittsburgh Brain Health InitiativeRECRUITING · started Nov 18, 2019ClinicalTrials.gov NCT04708613 · fetched Nov 12, 2026
- Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's DiseasePHASE3 · COMPLETED · started Mar 28, 2019ClinicalTrials.gov NCT03901105 · fetched Nov 12, 2026
- A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan InterpretationPHASE3 · COMPLETED · started Mar 26, 2019ClinicalTrials.gov NCT03901092 · fetched Nov 12, 2026
- Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's DiseaseRECRUITING · started Aug 30, 2018ClinicalTrials.gov NCT03019757 · fetched Nov 12, 2026
- Tau Screening Study in Patients With Early Symptomatic ADPHASE2 · COMPLETED · started Nov 21, 2017ClinicalTrials.gov NCT03322462 · fetched Nov 12, 2026
- Flortaucipir PET Imaging in Subjects With FTDPHASE1 · COMPLETED · started Apr 11, 2017ClinicalTrials.gov NCT03040713 · fetched Nov 12, 2026
- Flortaucipir 18F PET Imaging in BIOCARD StudyPHASE1 · TERMINATED · started Mar 23, 2017ClinicalTrials.gov NCT03052972 · fetched Nov 12, 2026
- 18F-AV-1451 High Resolution Autopsy StudyPHASE1 · COMPLETED · started Nov 26, 2016ClinicalTrials.gov NCT02350634 · fetched Nov 12, 2026
- PET Tau - Neurodegenerative Disease ImagingPHASE2_PHASE3 · RECRUITING · started Aug 23, 2016ClinicalTrials.gov NCT03143374 · fetched Nov 12, 2026
- 18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN StudyPHASE1 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02850146 · fetched Nov 12, 2026
- Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05PHASE2 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02795780 · fetched Nov 12, 2026
- 18F-AV-1451 Autopsy StudyPHASE3 · COMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02516046 · fetched Nov 12, 2026
- Tau Imaging in Professional FightersPHASE1 · COMPLETED · started Feb 18, 2015ClinicalTrials.gov NCT02278354 · fetched Nov 12, 2026
- Clinical Evaluation of Flortaucipir F 18PHASE2 · COMPLETED · started Dec 1, 2014ClinicalTrials.gov NCT02278367 · fetched Nov 12, 2026
- Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy VolunteersPHASE1 · COMPLETED · started Aug 12, 2014ClinicalTrials.gov NCT02167594 · fetched Nov 12, 2026
- 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic EncephalopathyPHASE2 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02079766 · fetched Nov 12, 2026
- Imaging Characteristics of a Follow-up 18F-AV-1451 ScanPHASE2 · TERMINATED · started May 1, 2014ClinicalTrials.gov NCT02051764 · fetched Nov 12, 2026
- Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD SubjectsPHASE2_PHASE3 · COMPLETED · started Dec 1, 2013ClinicalTrials.gov NCT02016560 · fetched Nov 12, 2026
- A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired SubjectsPHASE1 · COMPLETED · started Nov 13, 2013ClinicalTrials.gov NCT01992380 · fetched Nov 12, 2026
- Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired SubjectsEARLY_PHASE1 · COMPLETED · started Aug 16, 2013ClinicalTrials.gov NCT04474405 · fetched Nov 12, 2026
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 1, 2012ClinicalTrials.gov NCT01760005 · fetched Nov 12, 2026
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.PHASE2_PHASE3 · COMPLETED · started Dec 1, 2012ClinicalTrials.gov NCT04623242 · fetched Nov 12, 2026
- Effects of Brain Beta-Amyloid on Postoperative CognitionPHASE4 · ACTIVE_NOT_RECRUITING · started May 1, 2012ClinicalTrials.gov NCT01606488 · fetched Nov 12, 2026
- Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07PHASE3 · COMPLETED · started Mar 1, 2010ClinicalTrials.gov NCT01447719 · fetched Nov 12, 2026